Impact Of Prior Adjuvant Trastuzumab (At) On Clinical Characteristics, Patterns Of Recurrence And Outcome In 2863 Patients With Her2 Positive (Her2+) Metastatic Breast Cancer (Mbc)-Results From The French Esme Unicancer Program